Hybrigenics
Hybrigenics is a protein pathway-based company that identifies and validates new targets and therapeutic molecules by studying protein interactions and phenotypes in human cells. As a major actor in the post-genomic era, the company aims to elucidate the action of proteins, which participate as components of specific complexes or in interacting protein networks (biological pathways). Owing to the fact that most medications act on proteins or are proteins, the Hybrigenics approach makes it possible to shorten the stages between genomics and the development of new medications.
Hybrigenics is a protein pathway-based company that identifies and validates new targets and therapeutic molecules by studying protein interactions and phenotypes in human cells. As a major actor in the post-genomic era, the company aims to elucidate the action of proteins, which participate as components of specific complexes or in interacting protein networks (biological pathways). Owing to the fact that most medications act on proteins or are proteins, the Hybrigenics approach makes it possible to shorten the stages between genomics and the development of new medications.
The company has developed platforms for integrating experiments in biological organisms and in silico to allow the identification, selection, classification and validation of therapeutic targets